This healthcare company - long on the books of its two BDC lenders - went on non-accrual in the IIQ 2025 for the first time. The potential damage is relatively modest.
This post is for paying subscribers only
You might also like...
Jan
14
Carestream Health Inc.: Downgraded By S&P Following Sale Of Subsidiaries
4 min read
Dec
27
Khoros, LLC: IIIQ 2025 Update
3 min read
Dec
24
National Dentex Labs: IIIQ 2025 Update
2 min read
Dec
23
Conair Holdings: IIIQ 2025 Update
2 min read
Dec
22
Kellermeyer Bergenson Services/ KBS Inc.: IIIQ 2025 Update